Novo Nordisk

Em solidariedade à população afetada pelas recentes enchentes no Rio Grande do Sul, a Novo Nordisk segue se mobilizando para enfrentar esse momento crítico e desafiador. Continuamos atuando com a urgência que a situação pede e devida cautela para garantir que nossos medicamentos e doações cheguem a quem mais precisa, de forma segura, para cumprir seu papel de salvar vidas. Ao mesmo tempo, estamos trabalhando para manter o bem-estar de nossas pessoas que estão nas regiões afetadas e também fazem parte desta corrente de colaboração. Unindo esforços e centrados em nossos valores, nos manteremos ativos para oferecer o suporte que a população local necessita. BR24NNG00160

What a fantastic #ECO2024, exploring the latest advancements in obesity care. We look forward to seeing you again next year👋 #DrivingChange Catch up on all the highlights from this year's ECO and the latest in obesity related innovations over at Novo Nordisk CongressHub now 👇 https://lnkd.in/d7ANxye4 #Obesity #Innovation

We’re student favourites again! This time we’ve not only been ranked the #1 Most Attractive Employer in Denmark 2024 by students within Engineering/Natural Science, but also within Business and IT! Thank you to all the students who voted for us, it means the world to us to know that future talent sees Novo Nordisk as an attractive employer. We’re always looking to hire talented students, if you are interested in working at Novo Nordisk, explore our early talent career opportunities here: https://brnw.ch/21wJNoD

To understand #obesity, we must understand what is going on in our brains. Click to learn more about the brain’s influence on weight, and why we all gain and maintain weight differently: https://lnkd.in/d3UDXwTz #DrivingChange #Obesity

The #TIME100HEALTH list is out! Our CEO, Lars Fruergaard Jørgensen is featured: “By helping patients with obesity, we now have a dialogue about not just weight but about health and taking the burden off of the health system by preventing a number of co-morbidities related to obesity.” Congratulations to Lars and all the leaders working on novel treatments, fresh discoveries, and cutting-edge innovation!

Our quarterly results are out!    In the first three months of 2024, we have reached more than 41 million people with our diabetes and obesity medicines and taken important steps to defeat serious chronic diseases.    Learn more in the video below or here 👉 https://lnkd.in/gu4MH2U   #NovoNordisk #QuarterlyResults #DrivingChange

We are so proud of you 💙 A huge congratulations to our colleague Lotte Bjerre Knudsen on receiving the Mani L. Bhaumik Breakthrough of the Year Award together with Richard DiMarchi for their leadership in the development of GLP-1 receptor agonists to treat obesity. “In accepting this award, I represent a lot of people who have worked with me and us at Novo Nordisk through many years, including many academic collaborators. I have worked intensely on coming up with ideas and solving problems and in total it has now been exactly 33 years since I started working on GLP-1….I want to send a special message to all girls and women thinking about a career in science, whether it be in academia or in industry. Hopefully my own story can serve as an example and inspire more brilliant female scientific minds to pursue their passion and just go for it!” - Lotte Bjerre Knudsen The award has been established by celebrated physicist Dr. Mani L. Bhaumik and the American Association for the Advancement of Science, and is closely knit together with Science Magazine's Breakthrough of the Year nomination calling out significant scientific advancements.

Join us between 12-15 May at the European Congress on Obesity (#ECO2024)! We'll be rethinking and addressing #obesity for the benefit of the next generation and discussing our groundbreaking 2022 study 'ACTION teens' which explores the perceptions and attitudes towards teenagers living with obesity and the barriers they face to effective care from their caregivers and HCPs. Discover more at Novo Nordisk CongressHub - https://lnkd.in/gmDZgbGX

Half of the world lives in bigger cities, which is also where #obesity, #cardiovasculardisease, and #type2diabetes are rising fastest 👇

Why are cities key to defeating serious chronic diseases? Half of the world lives in bigger cities, which is also where #obesity, #cardiovasculardisease and #type2diabetes are rising fastest. So, if we can create healthier urban environments, it’s possible to help prevent chronic diseases from occurring in the first place. Building on a decade of experience, our Cities for Better Health partnership aims to tackle barriers to #urbanhealth around the world. Our ambition is to make healthy foods and physical activity more available, affordable and appealing for children and those most at risk of chronic disease. See more about the Cities for Better Health partnership here https://lnkd.in/dSdn5eVD #DrivingChange #Prevention